Viewing Study NCT06720532

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-13 @ 11:19 AM
Study NCT ID: NCT06720532
Status: RECRUITING
Last Update Posted: 2024-12-06
First Post: 2024-12-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial
Sponsor: Hannah Schaefer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Disease View
None Radiation Nephropathy View
None Metastatic Castrate Resistant Prostate Cancer (mCRPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None mCRPC View
None 177Lutetium View
None 177Lu-PSMA View
None radioligand therapy View